Skip to main content

Table 6 Measurements of plasmatic concentrations of cysteamine in 4 patients suffering from nephropathic infantile cystinosis after 6 h since the administration of cysteamine bitartrate

From: A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis

Patient

Cysteamine concentration (µM)

A

2.30

B

1.77

C

3.92

D

1.70

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172